The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Coiante Scott M since year 2005.
The trader's CIK number is 1608536.
At the time of the last reporting, Coiante Scott M was the SVP, Chief Financial Officer of Aprea Therapeutics, Inc. .
(stock ticker symbol APRE).
See this page for all insider trading activities at Aprea Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-10-07||APRE||Aprea Therapeutics, Inc.||Buy||2,500||15.00||37,500|
|2019-01-25||AGRX||Agile Therapeutics Inc||Option Ex||17,500||.00||0|
|2019-01-24||AGRX||Agile Therapeutics Inc||Option Ex||16,070||.00||0|
|2018-01-25||AGRX||Agile Therapeutics Inc||Option Ex||17,500||.00||0|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Coiante Scott M (SVP, Chief Financial Officer of Aprea Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.